New research finds that blood pressure and cholesterol lowering drugs continue to improve survival in patients with hypertension after more than a decade.
New research shows that very high levels of high-density lipoprotein (HDL or 'good') cholesterol may be associated with an increased risk of heart attack and death.
A study of more than 36,000 people followed for over two decades revealed that healthy individuals considered 'low-risk' still died from cardiovascular disease if they had high low-density lipoprotein (LDL) cholesterol. Without taking into account other risk factors, people with LDL cholesterol levels in the range of 100-159 mg/dL had a 30 to 40 percent higher risk of cardiovascular disease death.
Researchers have figured out why air sacs in the lungs clog up with a thick substance called surfactant in a brutal disease called Pulmonary Alveolar Proteinosis (PAP), and they show taking cholesterol-busting pills called statins can effectively treat the disease.
A new study showed for the first time that video games, in combination with fitness coaching and a step tracker, helped overweight children lose weight, lower their blood pressure and cholesterol and increase their physical activity.
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) -- also known as 'good cholesterol.' The findings bring into question the current use of total HDL cholesterol to predict heart disease risk.
Women with a history of preeclampsia or gestational hypertension in pregnancy developed chronic hypertension at a 2- to 3-fold higher rate and had 70 percent and 30 percent higher rates of type 2 diabetes and high cholesterol, respectively, than women who had normal blood pressure in pregnancy. These findings suggest that women with pregnancies complicated by high blood pressure may benefit from cardiovascular screening throughout their lives.
Fewer than six and more than ten hours of sleep per day are associated with metabolic syndrome and its individual components, according to a new study.
Adequate sleep duration and sleep quality may support healthy lipid profile among children and youth, according to new research. In addition, earlier circadian preference in childhood may contribute positively to the future health of the child.
MRSA evolved to become a deadly killer because it's wily and resilient. A new study, however, is figuring out how to turn one of its strengths against it.
A research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol.
One gram of fish oil a day could help reduce the pain of patients with osteoarthritis, a new study finds. Researchers also found that a reduction of weight for overweight and obese patients and the introduction of exercise tailored to mobility could also help ease the symptoms of osteoarthritis.
Eating up to 12 eggs a week does not increase cardiovascular risk factors in people with pre-diabetes or type 2 diabetes, new research finds -- despite conflicting dietary advice continuing around the world.
Analysis of high-resolution genomic data in a large study population reveals novel low-frequency polymorphisms that drive response to dietary lipids and medication.
Eating fatty fish increases the size and lipid composition of HDL particles in people with impaired glucose metabolism, according to a new study. These changes in the size and lipid composition of HDL particles make them beneficial for cardiovascular health. The study also found that camelina sativa oil decreases the number of harmful IDL particles.
Cholesterol-lowering drugs are more likely to save thousands of additional lives when used in people with higher levels of LDL cholesterol, or 'bad' cholesterol, according to a new study.
Decreased HDL and ApoA-l levels in the general population are associated with an increased risk of death from cardiomyopathy and heart failure. Researchers found the FA patients had serum ApoA-I levels lower than healthy control subjects. In preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich's ataxia (FA), a widely used cholesterol-lowering drug increased a precursor of HDL (high-density lipoprotein).
